Stay updated on Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing v3.5.4, which indicates a small platform or content update.
    Difference
    0.1%
    Check dated 2026-06-08T04:16:59.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    New page footer revision tag shows Revision: v3.5.4, and the previous Revision: v3.5.3 was removed. This is a metadata update to the page version, with no change to the study details or user-facing functionality.
    Difference
    0.1%
    Check dated 2026-05-17T10:35:57.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    ClinicalTrials.gov page footer was updated from revision v3.5.2 to v3.5.3, indicating a change to the site/versioning rather than the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:36:55.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.2, replacing the prior v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-18T13:28:22.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T01:08:16.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The page footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T18:25:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.